Intercept Pharmaceuticals
id:
intercept-pharmaceuticals-250-10072822
title:
Intercept Pharmaceuticals
text:
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical company
original url:
https://en.wikipedia.org/wiki/Intercept_Pharmaceuticals
date created:
date modified:
2024-01-08T21:50:47Z
main entity:
{"identifier":"Q16997126","url":"https://www.wikidata.org/entity/Q16997126"}
image:
fields total:
13
integrity:
14